These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29579857)

  • 1. Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation.
    De Gracia-Guindo MDC; Ruiz-Fuentes MDC; Galindo-Sacristán P; Osorio-Moratalla JM; Ruiz-Fuentes N; Rodriguez Granger J; Osuna-Ortega A
    Transplant Proc; 2018 Mar; 50(2):578-580. PubMed ID: 29579857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Tarasewicz A; Dębska-Ślizień A; Rutkowski B
    Transplant Proc; 2016 Jun; 48(5):1650-3. PubMed ID: 27496465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
    Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
    Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    Lee H; Park KH; Ryu JH; Choi AR; Yu JH; Lim J; Han K; Kim SI; Yang CW; Chung BH; Oh EJ
    PLoS One; 2017; 12(12):e0189488. PubMed ID: 29232714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Lee SM; Kim YJ; Yoo KH; Sung KW; Koo HH; Kang ES
    Ann Lab Med; 2017 May; 37(3):277-281. PubMed ID: 28224776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.
    Clari MÁ; Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; Bravo D; Amat P; Navarro D
    Clin Vaccine Immunol; 2012 May; 19(5):791-6. PubMed ID: 22379065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.
    Abate D; Saldan A; Mengoli C; Fiscon M; Silvestre C; Fallico L; Peracchi M; Furian L; Cusinato R; Bonfante L; Rossi B; Marchini F; Sgarabotto D; Rigotti P; Palù G
    J Clin Microbiol; 2013 Aug; 51(8):2501-7. PubMed ID: 23678073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
    Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
    Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yong MK; Cameron PU; Slavin M; Morrissey CO; Bergin K; Spencer A; Ritchie D; Cheng AC; Samri A; Carcelain G; Autran B; Lewin SR
    J Infect Dis; 2017 Jun; 215(11):1684-1694. PubMed ID: 28431019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study.
    Chanouzas D; Small A; Borrows R; Ball S
    PLoS One; 2018; 13(3):e0193968. PubMed ID: 29558479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.
    Nesher L; Shah DP; Ariza-Heredia EJ; Azzi JM; Siddiqui HK; Ghantoji SS; Marsh LY; Michailidis L; Makedonas G; Rezvani K; Shpall EJ; Chemaly RF
    J Infect Dis; 2016 Jun; 213(11):1701-7. PubMed ID: 26908740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
    Banas B; Steubl D; Renders L; Chittka D; Banas MC; Wekerle T; Koch M; Witzke O; Mühlfeld A; Sommerer C; Habicht A; Hugo C; Hünig T; Lindemann M; Schmidt T; Rascle A; Barabas S; Deml L; Wagner R; Krämer BK; Krüger B
    Transpl Int; 2018 Apr; 31(4):436-450. PubMed ID: 29284181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
    Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
    J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.
    Mena-Romo JD; Pérez Romero P; Martín-Gandul C; Gentil MÁ; Suárez-Artacho G; Lage E; Sánchez M; Cordero E
    J Infect; 2017 Oct; 75(4):336-345. PubMed ID: 28599954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and cytomegalovirus on CD8
    Cantisán S; Páez-Vega A; Santos F; Rodríguez-Benot A; Aguado R; Rivero A; Montejo M; Torre-Cisneros J; Solana R;
    Exp Gerontol; 2017 Sep; 95():98-106. PubMed ID: 28465043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
    Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
    Leone F; Gigliotti P; La Russa A; Lofaro D; Perri A; Vizza D; Lupinacci S; Toteda G; Bonofiglio M; Presta P; Talarico R; Aquino B; Bonofiglio R
    Transpl Infect Dis; 2019 Feb; 21(1):e13027. PubMed ID: 30431214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.